{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:44:28Z","timestamp":1790441068518,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The management of clival chordoma in our group shifted around 2013 to mostly endoscopic, and proton beam was introduced for our multidisciplinary team. Consecutive patients who had surgical resection from 1987 to 2021 were reviewed. A total of 58 patients (39 patients after 2013) were analyzed. The mean tumor size was 3.7 cm, and the most common location was the upper clivus (43%). Compared to before 2013, after 2013, the endoscopic endonasal approach was more common (90%, p &lt; 0.001), and more gross or near total resections (64%, p = 0.002) were attained. Ten cases (17%) were revision surgeries referred from elsewhere, and three cases (5%) underwent additional surgery elsewhere before adjuvant radiation. The postoperative cerebrospinal fluid leak occurred in 7%. Post-operative new cranial nerve deficits occurred in 32% before 2013, compared to 2.6% after 2013 (p = 0.004). For cases before 2013, 10 patients (53%) recurred during the median follow-up of 144 months (mean, 142 months), whereas for cases after 2013, seven patients (18%) recurred with a median follow-up of 35 months (mean, 42 months). 5-year progression-free survival was 58%, and 5-year overall survival was 87%. A specialized multidisciplinary team improved the resection rate compared to a historical cohort with an excellent morbidity profile.<\/jats:p>","DOI":"10.3390\/cancers14205104","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T21:18:02Z","timestamp":1666127882000},"page":"5104","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mayo Clinic Clival Chordoma Case Series: Impact of Endoscopic Training on Clinical Care"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3664-9245","authenticated-orcid":false,"given":"Sukwoo","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Laack","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Department of Otolaryngology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janalee K.","family":"Stokken","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Department of Otolaryngology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Janus","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-2727","authenticated-orcid":false,"given":"Garret","family":"Choby","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Department of Otolaryngology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-7870","authenticated-orcid":false,"given":"Jamie J.","family":"Van Gompel","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55902, USA"},{"name":"Department of Otolaryngology, Mayo Clinic, Rochester, MN 55902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008947301735","article-title":"Chordoma: Incidence and survival patterns in the United States, 1973\u20131995","volume":"12","author":"McMaster","year":"2001","journal-title":"Cancer Causes Control"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Barber, S.M., Sadrameli, S.S., Lee, J.J., Fridley, J.S., Teh, B.S., Oyelese, A.A., Telfeian, A.E., and Gokaslan, Z.L. (2021). Chordoma-Current Understanding and Modern Treatment Paradigms. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051054"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.athoracsur.2020.07.093","article-title":"Cardiac Metastasis of Sacral Chordoma","volume":"111","author":"Barletta","year":"2021","journal-title":"Ann. Thorac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcp\/72.5.765","article-title":"Chordoma. A clinicopathologic study of metastasis","volume":"72","author":"Chambers","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"106305","DOI":"10.1016\/j.clineuro.2020.106305","article-title":"Clivus chordomas: Heterogeneous tumor extension requires adapted surgical approaches","volume":"199","author":"Zweckberger","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3171\/2020.5.JNS20925","article-title":"The management of clival chordomas: An Italian multicentric study","volume":"135","author":"Cavallo","year":"2020","journal-title":"J. Neurosurg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3171\/2016.11.JNS162082","article-title":"Clival chordomas: Considerations after 16 years of endoscopic endonasal surgery","volume":"128","author":"Zoli","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hed.23415","article-title":"Clival chordomas: A pathological, surgical, and radiotherapeutic review","volume":"36","author":"Gardner","year":"2014","journal-title":"Head Neck"},{"key":"ref_9","unstructured":"Fletcher, C., Bridge, J.A., Hogendoorn, P.C.W., and Mertens, F. (2013). WHO Classification of Tumours of Soft Tissue and Bone: WHO Classification of Tumours, World Health Organization."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.wneu.2011.08.034","article-title":"Gasket seal closure for extended endonasal endoscopic skull base surgery: Efficacy in a large case series","volume":"80","author":"Anand","year":"2013","journal-title":"World Neurosurg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11102-013-0508-y","article-title":"A panoramic view of the skull base: Systematic review of open and endoscopic endonasal approaches to four tumors","volume":"17","author":"Graffeo","year":"2014","journal-title":"Pituitary"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.wneu.2017.10.146","article-title":"Endoscopic Approach to Clival Chordomas: The Northwestern Experience","volume":"110","author":"Rahme","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_13","first-page":"5213744","article-title":"Factors Influencing Cerebrospinal Fluid Leaking following Pituitary Adenoma Transsphenoidal Surgery: A Meta-Analysis and Comprehensive Review","volume":"2022","author":"Zhang","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3171\/2016.9.JNS16559","article-title":"Clinical features and surgical outcomes of patients with skull base chordoma: A retrospective analysis of 238 patients","volume":"127","author":"Wang","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10143-020-01318-y","article-title":"Microsurgical versus endoscopic trans-sphenoidal approaches for clivus chordoma: A pooled and meta-analysis","volume":"44","author":"Cannizzaro","year":"2021","journal-title":"Neurosurg. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10143-013-0503-9","article-title":"Endoscopic endonasal approach in the management of skull base chordomas\u2014Clinical experience on a large series, technique, outcome, and pitfalls","volume":"37","author":"Chibbaro","year":"2014","journal-title":"Neurosurg. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1227\/01.NEU.0000338071.01241.E2","article-title":"Endoscopic endonasal approach for clival chordomas","volume":"64","author":"Stippler","year":"2009","journal-title":"Neurosurgery"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.wneu.2011.02.026","article-title":"The Endoscope-Assisted Ventral Approach Compared with Open Microscope-Assisted Surgery for Clival Chordomas","volume":"76","author":"Komotar","year":"2011","journal-title":"World Neurosurg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.wneu.2017.10.010","article-title":"Prognostic Factors in Skull Base Chordoma: A Systematic Literature Review and Meta-Analysis","volume":"109","author":"Zou","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/lary.28003","article-title":"Olfactory outcomes after endoscopic skull base surgery: A systematic review and meta-analysis","volume":"129","author":"Yin","year":"2019","journal-title":"Laryngoscope"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3171\/2021.6.JNS21517","article-title":"The Suprasellar Meningioma Patient-Reported Outcome Survey: A disease-specific patient-reported outcome measure for resection of suprasellar meningioma","volume":"136","author":"Khalafallah","year":"2022","journal-title":"J. Neurosurg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/alr.22783","article-title":"Quality-of-life instruments in endoscopic endonasal skull base surgery-A practical systematic review","volume":"11","author":"Shukla","year":"2021","journal-title":"Int. Forum. Allergy Rhinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/j.wneu.2022.04.005","article-title":"Quality of Life After Endoscopic Skull Base Surgery: Validation and Reliability of the Italian Version of the Sino-Nasal Outcome Test for Neurosurgery (SNOT-NC)","volume":"163","author":"Riva","year":"2022","journal-title":"World Neurosurg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11912-022-01214-2","article-title":"Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors","volume":"24","author":"Jozaghi","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00701-017-3163-7","article-title":"Clival chordoma: A single-centre outcome analysis","volume":"159","author":"Dammann","year":"2017","journal-title":"Acta Neurochir."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"565945","DOI":"10.3389\/fonc.2020.565945","article-title":"Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.ejca.2015.07.038","article-title":"Imatinib in advanced chordoma: A retrospective case series analysis","volume":"51","author":"Hindi","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1338235","DOI":"10.1080\/2162402X.2017.1338235","article-title":"First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies","volume":"6","author":"Migliorini","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1055\/s-0041-1722933","article-title":"Systematic Review Comparing Open versus Endoscopic Surgery in Clival Chordomas and a 10-Year Single-Center Experience","volume":"83","author":"Ravindran","year":"2022","journal-title":"J. Neurol. Surg. B Skull Base"},{"key":"ref_30","first-page":"519","article-title":"Tailored surgical strategy in clival chordomas: An extraordinary selection bias that limits approach comparison","volume":"62","author":"Broggi","year":"2018","journal-title":"J. Neurosurg. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10143-018-1020-7","article-title":"The timing of fusion surgery for clival chordoma with occipito-cervical joint instability: Before or after tumor resection?","volume":"43","author":"Park","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3171\/2009.10.SPINE09393","article-title":"Image-guided, endoscopic, transcervical resection of cervical chordoma: Technical note","volume":"12","author":"Hsu","year":"2010","journal-title":"J. Neurosurg. Spine SPI"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S1470-2045(14)71190-8","article-title":"Building a global consensus approach to chordoma: A position paper from the medical and patient community","volume":"16","author":"Stacchiotti","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3892\/etm.2017.4736","article-title":"Radioresistance of chordoma cells is associated with the ATM\/ATR pathway, in which RAD51 serves as an important downstream effector","volume":"14","author":"Zhang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijrobp.2008.12.055","article-title":"Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: First long-term report","volume":"75","author":"Ares","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/COC.0b013e318248dc6f","article-title":"Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas","volume":"36","author":"Bugoci","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s12032-014-0886-7","article-title":"Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis","volume":"31","author":"Chen","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.wneu.2013.01.131","article-title":"A comparison of cell-cycle markers in skull base and sacral chordomas","volume":"82","author":"Yakkioui","year":"2014","journal-title":"World Neurosurg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/NEN.0b013e3182a065d0","article-title":"Molecular and clinical risk factors for recurrence of skull base chordomas: Gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis","volume":"72","author":"Kitamura","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3171\/2018.3.JNS172321","article-title":"Prospective validation of a molecular prognostication panel for clival chordoma","volume":"130","author":"Zenonos","year":"2019","journal-title":"J. Neurosurg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s00701-017-3266-1","article-title":"Multidisciplinary management of clival chordomas; long-term clinical outcome in a single-institution consecutive series","volume":"159","author":"Bartek","year":"2017","journal-title":"Acta Neurochir."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00701-020-04219-7","article-title":"Peri-operative prognostic factors for primary skull base chordomas: Results from a single-center cohort","volume":"163","author":"Broggi","year":"2021","journal-title":"Acta Neurochir."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00401-016-1574-9","article-title":"Poorly differentiated chordoma with SMARCB1\/INI1 loss: A distinct molecular entity with dismal prognosis","volume":"132","author":"Hasselblatt","year":"2016","journal-title":"Acta Neuropathol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5104\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:56:32Z","timestamp":1760144192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":43,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cancers14205104"],"URL":"https:\/\/doi.org\/10.3390\/cancers14205104","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]}}}